Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Most cancer cells show increased chromosome missegregation, known as chromosomal instability (CIN), which promotes cancer progression and drug resistance. The underlying causes of CIN in cancer cells are not fully understood. Here we found that breast cancer cell lines show a reduced kinetochore localization of ROD, ZW10, and Zwilch, components of the fibrous corona, compared with non‐transformed breast epithelial cell lines. The fibrous corona is a structure formed on kinetochores before their end‐on attachment to microtubules and plays a role in efficient kinetochore capture and the spindle assembly checkpoint. The reduction in the fibrous corona was not due to reduced expression levels of the fibrous corona components or to a reduction in outer kinetochore components. Kinetochore localization of Bub1 and CENP‐E, which play a role in the recruitment of the fibrous corona to kinetochores, was reduced in cancer cell lines, presumably due to reduced activity of Mps1, which is required for their recruitment to kinetochores through phosphorylating KNL1. Increasing kinetochore localization of Bub1 and CENP‐E in cancer cells restored the level of the fibrous corona. Cancer cell lines showed a reduced capacity to nucleate microtubules from kinetochores, which was recently shown to be dependent on the fibrous corona, and increasing kinetochore localization of Bub1 and CENP‐E restored the microtubule nucleation capacity on kinetochores. Our study revealed a distinct feature of cancer cell lines that may be related to CIN.

          Abstract

          Cancer cell lines show a reduction in the fibrous corona, a structure on kinetochores in early mitosis. This reduction is supposed to be due to reduced kinetochore localization of Bub1 and CENP‐E, caused by reduced Mps1 activity. Reduced fibrous corona in cancer cell lines reduces the capacity to nucleate microtubules from kinetochores, which may cause CIN through inefficient formation of kinetochore–microtubule attachments.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Investigation of the freely available easy-to-use software ‘EZR' for medical statistics

          Y Kanda (2012)
          Although there are many commercially available statistical software packages, only a few implement a competing risk analysis or a proportional hazards regression model with time-dependent covariates, which are necessary in studies on hematopoietic SCT. In addition, most packages are not clinician friendly, as they require that commands be written based on statistical languages. This report describes the statistical software ‘EZR' (Easy R), which is based on R and R commander. EZR enables the application of statistical functions that are frequently used in clinical studies, such as survival analyses, including competing risk analyses and the use of time-dependent covariates, receiver operating characteristics analyses, meta-analyses, sample size calculation and so on, by point-and-click access. EZR is freely available on our website (http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmed.html) and runs on both Windows (Microsoft Corporation, USA) and Mac OS X (Apple, USA). This report provides instructions for the installation and operation of EZR.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

            Intratumor heterogeneity, which fosters tumor evolution, is a key challenge in cancer medicine. Here, we review data and technologies that have revealed intra-tumor heterogeneity across cancer types and the dynamics, constraints, and contingencies inherent to tumor evolution. We emphasize the importance of macro-evolutionary leaps, often involving large-scale chromosomal alterations, in driving tumor evolution and metastasis and consider the role of the tumor microenvironment in engendering heterogeneity and drug resistance. We suggest that bold approaches to drug development, harnessing the adaptive properties of the immune-microenvironment while limiting those of the tumor, combined with advances in clinical trial-design, will improve patient outcome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Context is everything: aneuploidy in cancer

              Cancer is driven by multiple types of genetic alterations, which range in size from point mutations to whole-chromosome gains and losses, known as aneuploidy. Chromosome instability, the process that gives rise to aneuploidy, can promote tumorigenesis by increasing genetic heterogeneity and promoting tumour evolution. However, much less is known about how aneuploidy itself contributes to tumour formation and progression. Unlike some pan-cancer oncogenes and tumour suppressor genes that drive transformation in virtually all cell types and cellular contexts, aneuploidy is not a universal promoter of tumorigenesis. Instead, recent studies suggest that aneuploidy is a context-dependent, cancer-type-specific oncogenic event that may have clinical relevance as a prognostic marker and as a potential therapeutic target.
                Bookmark

                Author and article information

                Contributors
                kenji.iemura.a6@tohoku.ac.jp
                kozo.tanaka.d2@tohoku.ac.jp
                Journal
                Cancer Sci
                Cancer Sci
                10.1111/(ISSN)1349-7006
                CAS
                Cancer Science
                John Wiley and Sons Inc. (Hoboken )
                1347-9032
                1349-7006
                27 November 2024
                February 2025
                : 116
                : 2 ( doiID: 10.1111/cas.v116.2 )
                : 420-431
                Affiliations
                [ 1 ] Department of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC) Tohoku University Sendai Japan
                [ 2 ] Department of Molecular Oncology, Graduate School of Medicine Tohoku University Sendai Japan
                [ 3 ] Department of Molecular Oncology, Graduate School of Life Sciences Tohoku University Sendai Japan
                Author notes
                [*] [* ] Correspondence

                Kozo Tanaka and Kenji Iemura, Department of Molecular Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4‐1 Seiryo‐machi, Aoba‐ku, Sendai, Miyagi 980‐8575, Japan.

                Email: kozo.tanaka.d2@ 123456tohoku.ac.jp and kenji.iemura.a6@ 123456tohoku.ac.jp

                Author information
                https://orcid.org/0000-0003-0829-5299
                https://orcid.org/0000-0001-6086-2858
                Article
                CAS16406 CAS-OA-1695-2024.R1
                10.1111/cas.16406
                11786318
                39604214
                fb3b2f13-5219-404a-8d3e-5577322523d0
                © 2024 The Author(s). Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 21 October 2024
                : 03 July 2024
                : 08 November 2024
                Page count
                Figures: 6, Tables: 0, Pages: 12, Words: 7500
                Funding
                Funded by: Ministry of Education, Culture, Sports, Science and Technology , doi 10.13039/501100001700;
                Award ID: 18H04896
                Award ID: 21H05738
                Award ID: 23H04272
                Funded by: Yamaguchi Educational and Scholarship Foundation
                Funded by: Mochida Memorial Foundation for Medical and Pharmaceutical Research , doi 10.13039/501100005865;
                Funded by: Japan Science and Technology Agency , doi 10.13039/501100002241;
                Award ID: JPMJAX2112
                Funded by: Takeda Science Foundation , doi 10.13039/100007449;
                Funded by: The Pharmacological Research Foundation. Tokyo
                Funded by: Japan Society for the Promotion of Science , doi 10.13039/501100001691;
                Award ID: 15H04368
                Award ID: 16H06635
                Award ID: 16K14604
                Award ID: 18H02434
                Award ID: 18K15234
                Award ID: 22H02614
                Award ID: 23K05629
                Categories
                Original Article
                ORIGINAL ARTICLE
                Cell, Molecular, and Stem Cell Biology
                Custom metadata
                2.0
                February 2025
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.3 mode:remove_FC converted:01.02.2025

                Oncology & Radiotherapy
                breast cancer,bub1,cenp‐e,chromosomal instability,fibrous corona,rzz complex
                Oncology & Radiotherapy
                breast cancer, bub1, cenp‐e, chromosomal instability, fibrous corona, rzz complex

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content1,087

                Most referenced authors420